For personal use only
|
|
- Lucy Rose
- 5 years ago
- Views:
Transcription
1 ASX: VRX Diggers & Dealers August 2012 Bruce Maluish, Managing Director 1
2 Disclaimer & Competent Person This presentation was prepared with due care and attention and is current at the date of the presentation. The summary is not an offer or recommendation to purchase or subscribe for securities in Ventnor Resources Limited or to retain any securities currently held. It does not take into account the potential and current individual investment objectives or the financial situation of investors. Actual results may materially vary from any forecasts (where applicable) in this presentation. Before making or varying any investment in securities in Ventnor Resources Limited, all investors should consider the appropriateness of that investment in light of their individual investment objectives and financial situation. The information in this presentation that relates to Exploration Results is based on information compiled by Mr David Reid who is a Member of the Australasian Institute of Mining and Metallurgy (MAusIMM). Mr Reid is an employee of Ventnor Resources Limited. Mr Reid has sufficient experience which is relevant to the style of mineralisation and type of deposit under consideration and to the activity which he is undertaking to qualify as a Competent Person as defined in the 2004 Edition of the Australasian Code for Reporting of Exploration Results, Mineral Resources and Ore Reserves. Mr Reid consents to the inclusion in this presentation the matters based on information provided by him and in the form and context in which it appears. 2
3 Ventnor Resources Projects 3
4 Thaduna / Green Dragon Copper Project Western Australia 4
5 Thaduna/Green Dragon Location 5
6 Ventnor Gascoyne Tenements 6
7 Thaduna/Green Dragon 175 Kms northeast of Meekatharra 4PLs covering 604 Ha 40 kms east of Sandfire Resources De Grussa Significant drilling results from 35,000 metres drilling JORC Resource Q
8 Thaduna Historic mining and production completed 1971 Prior production 30, % Cu Historic drilling % Cu from 80 m First phase April 2011 included: % Cu from 80 m; % Cu from 87 m and % Cu from 75 m. 8
9 Thaduna 9
10 10
11 Thaduna 11
12 Typical Hydrothermal Copper Geology 12
13 Thaduna Second phase July 2011: % Cu from 30 m; % Cu from 121 m; % Cu from 100 m; % Cu from 122 m and % Cu from 100 m. 13
14 Thaduna 14
15 Thaduna Announcement: 24 January 2012 from 3 rd phase drilling % Cu from 111 metres (THRC113) including % Cu from 134 m downhole; % Cu from 125 metres (THRC114) including % Cu from 127 m downhole and ended in mineralisation, 3.70% Cu at EOH, extended by diamond drilling 15
16 Thaduna Copper Geology 16
17 Thaduna Announcement 12 March 2012 THRC119 has been drilled with a diamond tail and encountered significant sulphide mineralisation 14.0 m from m to m down hole Targeting down plunge extension to the main lode Increasing in grade and thickness with depth 17
18 Thaduna THRC metres 18
19 Thaduna THRC metres 19
20 Thaduna Announcement 1 August % Cu (includes % Cu and 29.7 g/t Ag) % Cu % Cu % Cu % Cu % Cu % Cu % Cu % Cu % Cu 20
21 Thaduna 21
22 Thaduna 22
23 Thaduna Long Section 23
24 Thaduna Long Section Inset 24
25 25
26 Chalcopyrite Mineralogy Mineral Name Area Mass % Background C halcopyrite Bornite C ovellite Quartz C hlorite Albite Micas Rutile/Anatase Other minerals Mineral Name Area Mass % Cu mass % Chalcopyrite Bornite Covellite Quartz Chlorite Albite Micas Rutile/Anatase Other minerals Total
27 Thaduna Proposed Mining Infrastructure 27
28 Thaduna 28
29 Green Dragon 29
30 Green Dragon Prior production 9, % Cu Historic drilling % Cu from 97 m First phase drilling April 2011: % Cu from 64 m, % Cu from 44 m, % Cu from 79 m, % Cu from 85 m 30
31 Green Dragon Second phase July 2011: % Cu from 85 m; 2.98% Cu from 44 m; 7.86% Cu from 60 m; 6.07% Cu from 80 m; 5.07% Cu from 64 m and 5.93% Cu from 88 m. 31
32 Green Dragon Third phase November 2011: 6.07% Cu from 80 m; 5.07% Cu from 64 m; 5.93% Cu from 88 m; 10.96% Cu from 37 m and 4.00% Cu from surface. Phase 4 Drilling completed 32
33 Green Dragon 33
34 Green Dragon
35 Thaduna/Green Dragon Project Fourth Phase drilling nears completion JORC Resource Q Preliminary scoping study to follow Many mining permit studies completed Development options to be considered 35
36 Thaduna Proposed Mining Infrastructure New Plant Nearby 36
37 Capital Structure Issued Shares Options Total M 25.4 M Cash on hand $2.9 June 30 Market 50c $37 M 37
First Results Prospector Drilling Program
24 June 2008 Manager Company Announcements Company Announcements Office Australian Stock Exchange Limited Level 10, 20 Bond Street SYDNEY NSW 2000 ABN 42 082 593 235 Electronic delivery No of pages: 10
More informationASX/Media Announcement 24 December 2010
ASX/Media Announcement 24 December 2010 ANDY WELL PROJECT UPDATE Diamond drilling continues to deliver high-grade results RC drilling continues at Wilber Lode to define a JORC Resource Southern extensions
More informationMutiny continues to hit high grade gold and copper intersections in latest Deflector drilling
Mutiny continues to hit high grade gold and copper intersections in latest Deflector drilling New Diamond drill results within the Deflector Deposit include: 3.3m @ 79g/t Au and 10.5% Cu from 62m in 12DD042
More informationSCOUT DRILLING COMPLETED ON KELLERBERRIN URANIUM PROJECT
ASX ANNOUNCEMENT SCOUT DRILLING COMPLETED ON KELLERBERRIN URANIUM PROJECT ASX Code: MDX ABN: 28 106 866 442 Corporate Description Mindax's Mt Forrest Iron Project is progressing through feasibility with
More information28 April 2017 ASX Code: COY. March 2017 Quarterly Activity Report
28 April 2017 ASX Code: COY The following report details the operating and corporate activities of Coppermoly Ltd (Coppermoly or the Company) for the quarter ended 31 March 2017 and to the date of this
More informationDisclaimer. Matrix Metals Limited Presentation October
Matrix Metals Limited Presentation October 2008 Disclaimer The material used is this presentation is intended to be a summary of selected geological data, current and proposed activities, as well as resource
More informationRiesling Base Metal Project pxrf Soil Geochemistry
pxrf Soil Geochemistry Ken Harvey Non-executive Director Superior Resources Limited Riesling Located 280km NW Townsville & 17km SSW of Mount Surprise, North Queensland VMS (or Broken Hill) type deposit
More informationTRI ORIGIN MINERALS LTD
TRI ORIGIN MINERALS LTD Mines And Wines Conference September 2007 Woodlawn Zinc-Copper Projects ASX Code: TRO DISCLAIMER The Information contained in this presentation has been prepared using the information
More informationKihabe Zn, Pb, Ag Project Botswana
Kihabe Zn, Pb, Ag Project Botswana 8/800 Albany Highway East Victoria Park, WA 6101 www.mountburgess.com mtb@mountburgess.com ASX: MTB Kihabe 14.4Mt Resource* Nxuu 10.9Mt Resource* * See slide 5 for Resource
More informationFor personal use only
L1, 254 Railway Parade, West Leederville WA 6007 PO Box 1245, West Leederville WA 6901 T: +61 8 9363 7800 e: office@platypusminerals.com.au www.platypusminerals.com.au ASX/Media Announcement Perth: 18
More informationFor personal use only
Exploration Office Level 3, 100 Pirie Street ADELAIDE SA 5000 ABN: 96 110 336 733 Tel: +61 8 8232 8320 Fax: +61 8 8232 8811 www.monaxmining.com.au 21 December 2016 Significant Sampling Results at Litchfield
More informationBISIE PROJECT UPDATE
Level 3, Gotthardstrasse 20, CH-6300, Zug, Switzerland Tel: +41 41 711 02 81 www.alphaminresources.com BISIE PROJECT UPDATE News Release 2014-10-27 VANCOUVER, CANADA October 27 th, 2014 Alphamin Resources
More informationAccelerated Mining and Gold Production Completion of Strategic Alliance with Territory Resources for Tennant Creek $2m Placement at 56.
ASX Announcement 6 September 2018 ASX: ERM Accelerated Mining and Gold Production Completion of Strategic Alliance with Territory Resources for Tennant Creek $2m Placement at 56.8% premium Highlights Emmerson
More informationFor personal use only
ASX RELEASE Suite 2501 Level 25 St Martins Tower 31 Market Street Sydney NSW 2000 Australia (PO Box Q638 QVB Market Street NSW 1230 Australia) Tel: +61 (02) 9283 3880 8 October 2018 ASSAY RESULTS RECEIVED
More informationPRELIMINARY DRILLING RESULTS FROM FIVE NEW DRILL HOLES EXTEND IRON MINERALISATION AT MARIELA
LATIN RESOURCES LIMITED ACN: 131 405 144 Suite 2, Level 1, 254 Rokeby Road Subiaco, Western Australia, 6008. P 08 9485 0601 F 08 9321 6666 E info@latinresources.com.au 30 January 2013 PRELIMINARY DRILLING
More informationDNI Metals - First 12 of 28 Diamond Core Assays Received; Including 34m Grading 5.63% Graphitic Carbon
DNI Metals - First 12 of 28 Diamond Core Assays Received; Including 34m Grading 5.63% Graphitic Carbon Toronto, Ontario--(Newsfile Corp. - December 7, 2017) - DNI Metals Inc. (DNI: CSE) (FSE: DG7N) (OTC
More informationStar Zinc Project Update Released 07:00 15-Oct-2018
Regulatory Story Galileo Resources PLC - GLR Star Zinc Project Update Released 07:00 15-Oct-2018 RNS Number : 9593D Galileo Resources PLC 15 October 2018 For immediate release 15 October 2018 Galileo Resources
More informationJanuary A different kind of Zinc Explorer
January 2018 A different kind of Zinc Explorer Cautionary Statement This presentation contains certain statements that may be deemed "forward-looking statements". All statements in this presentation, other
More informationInvestor Presentation
ASX:THC B u i l d i n g a M e d i c i n a l C a n n a b i s B u s i n e s s Investor Presentation November 2017 DISCLAIMER The material in this presentation (material) is not and does not constitute an
More informationAyawilca Zinc Project Peru: Targeting Resource Growth in 2017
Ayawilca Zinc Project Peru: Targeting Resource Growth in 2017 PDAC Peru Day Presentation Dr Graham Carman Tinka Resources Limited March 6, 2017 OTC: TKRFF Disclaimer This presentation is not directed to,
More informationASX/Media Announcement
L1, 254 Railway Parade, West Leederville WA 6007 PO Box 1245, West Leederville WA 6901 T: +61 8 9363 7800 e: office@platypusminerals.com.au www.platypusminerals.com.au ASX/Media Announcement Perth: 19
More informationWhite Rose Research Online URL for this paper: Version: Accepted Version
This is a repository copy of Magmatic Hydrothermal Fluids at the Sedimentary Rock-hosted, Intrusion-related Telfer Gold-Copper Deposit, Paterson Orogen, Western Australia: P-T-X Constraints on the Ore
More informationOPEMISKA COPPER MINE COMPLEX. PORE: TSXV powerore.com
OPEMISKA COPPER MINE COMPLEX PORE: TSXV powerore.com FORWARD LOOKING STATEMENTS We are in the mineral exploration and development business. It is inherently risky, and all potential investors should be
More informationWONGAN HILLS, W.A. - base metals and gold project
ASX ANNOUNCEMENT ABN 46 006 045 790 www.cullenresources.com.au ASX Symbol: CUL 3 May 2018 New assays confirm and extend geochemical anomalies WONGAN HILLS, W.A. - base metals and gold project Results of
More informationASX/Media Announcement
L1, 254 Railway Parade, West Leederville WA 6007 PO Box 1245, West Leederville WA 6901 T: +61 8 9363 7800 e: office@platypusminerals.com.au www.platypusminerals.com.au ASX/Media Announcement Perth: 21
More informationFor personal use only
ASX RELEASE (23 rd March 2018) AGM PowerPoint Presentaion In accordance with the requirements of Listing Rule 3.1 we submit the attached material being distributed at the Company s Annual General Meeting
More informationFor personal use only
Virtus Health (ASX. VRT) Sue Channon CEO and Glenn Powers CFO Navigating Future Growth, UBS Australasian Conference 7 November, 2016 DISCLAIMER 2 The material in this presentation has been prepared by
More informationDELICA D:5 ACTIVE GEAR 0
DELICA D:5 ACTIVE GEAR 0 1 1. FY2017 1Q Results 2. FY2017 1Q Results by Region 3. FY2017 Forecast 4. Initiatives for the Future FY2017 1Q Results Summary (vs. FY2016 1Q) (Apr-Jun 2016) (Apr-Jun 2017) (billion
More informationFor personal use only
ASX Announcement 12 July 2017 ASX Code: ARM Aurora Minerals Group of Companies Diversified Minerals Exploration via direct and indirect interests Predictive Discovery Limited (ASX: PDI) 39.6% - Gold Exploration
More informationASX/Media Announcement
L1, 254 Railway Parade, West Leederville WA 6007 PO Box 1245, West Leederville WA 6901 T: +61 8 9363 7800 e: office@platypusminerals.com.au www.platypusminerals.com.au ASX/Media Announcement Perth: 24
More informationFor personal use only
ASX/Media Announcement 27th May 2016 SUBSTANTIAL RESOURCE UPGRADE FOR COPI NORTH HEAVY MINERAL SAND DEPOSIT Highlights Copi North Resource tonnage increased by 22% from 11.6 Mt to 14.2 Mt Indicated category
More informationNOXOPHARM CORPORATE PRESENTATION FNN SHAW&PARTNERS INVESTOR EVENT ASX: NOX
Date: 14 August, 2018 Sydney, Australia ASX: NOX Noxopharm Limited NOXOPHARM CORPORATE PRESENTATION FNN SHAW&PARTNERS INVESTOR EVENT ABN 50 608 966 123 Registered Office and Operations Office: Suite 3,
More informationHISTORICAL OVERVIEW OF GOLD COPPER MINERAL DISCOVERIES & MINE DEVELOPMENTS IN THE PHILIPPINES
15 10 05 120 125 120 125 15 10 05 HISTORICAL OVERVIEW OF GOLD COPPER MINERAL DISCOVERIES & MINE DEVELOPMENTS IN THE PHILIPPINES Spain China 3rd 1 th century North America Java 16 th 19 th century12 th
More informationFor personal use only
AusCann Makes Major Progress Towards Production of Cannabinoid Medicines During FY18 Highlights Undertook comprehensive pharmaceutical development project to create an optimal dosage form cannabinoid medicine
More informationBrisa Concessão Rodoviária. 1Q 2017 Traffic Update
Brisa Concessão Rodoviária 1Q 2017 Traffic Update 15 th May 2017 Disclaimer The information contained herein ( Information ) has been prepared by Brisa Concessão Rodoviária, S.A. ("BCR") and which, according
More informationLao People s Democratic Republic
Authentic in Lao Only Lao People s Democratic Republic Peace Independence Democracy Unity Prosperity Ministry of Mines and Energy Ref. 1116/MEM Vientiane Capital, dated 21.09.2010 Regulation on Sending
More informationImproving the lives of people with neurological conditions. Annual General Meeting Neurotech International Limited (ASX: NTI) November 2017
Improving the lives of people with neurological conditions Annual General Meeting Neurotech International Limited (ASX: NTI) November 2017 Neurotech Overview Medical device company, focussed on the development
More informationExpanding Resources in the Caribbean
TSX.V: UGD Expanding Resources in the Caribbean CORPORATE PRESENTATION; September 2017 Forward Looking Statements Certain statements contained in this presentation, including statements regarding events
More informationTSX: LUN OMX: LUMI Corpora Corpor t a e t Presen esen a t tion
TSX: LUN OMX: LUMI Corporate Presentation November 2013 Cautionary Statements Caution Regarding Forward Looking Statements This presentation contains forward looking statements. These forward looking statements
More informationAcquisition of BP s Interests in Bruce, Keith and Rhum Fields in the North Sea Frequently Asked Questions
Acquisition of BP s Interests in Bruce, Keith and Rhum Fields in the North Sea Frequently Asked Questions 1. What is Serica buying? Serica Energy is buying the Bruce, Keith and Rhum (BKR) package of assets
More informationSpiros Nomikos Chief Executive Officer Solvay Sodi Bulgaria
Spiros Nomikos Chief Executive Officer Solvay Sodi Bulgaria FINANCIAL TIMES INVESTING IN BULGARIA CONFERENCE Investment Opportunities in Bulgaria The Case of Solvay Sodi Spiros Nomikos CEO of Solvay Sodi
More informationFor personal use only
ASX ANNOUNCEMENT 22 NOVEMBER 2017 AGM ADDRESSES FROM THE CHAIRMAN & CEO 22 November 2017 Cann Group Limited (ASX: CAN) is pleased to provide the following addresses to be delivered by its Chairman Allan
More informationGlobal Influenza Vaccine Market: Industry Analysis & Outlook
Industry Research by Koncept Analytics Global Influenza Vaccine Market: Industry Analysis & Outlook ----------------------------------------- January 2017 1 Executive Summary Influenza, also known as flu,
More informationShareholder Presentation Annual Meeting 2018
Shareholder Presentation Annual Meeting 2018 FY 18 HIGHLIGHTS Strong sales growth of 2 nd Gen TruScreen to China commenced during 4 th quarter. (50% of the year s sales were generated in the fourth quarter)
More informationASX Investor Presentation
ASX Investor Presentation Sydney, Australia Dr Peter Neustadt Executive Chairman and CEO November 2014 Copyright and registered trademark notice ASX Investor Presentation Page 0 Who we are SomnoMed Limited
More informationInvestor presentation. Bioshares Biotech Summit July 2017
Investor presentation Bioshares Biotech Summit 2017 22 July 2017 1 Disclaimer Some of the information in this presentation may refer to Dimerix Limited ( Dimerix or the Company ) based on information available
More informationFor personal use only
A.B.N. 52 007 626 575 20 November 2017 ASX:JRV NICO YOUNG COBALT-NICKEL LATERITE: UPDATED MINERAL RESOURCE HIGHLIGHTS JORC Inferred resource of 167.8Mt @ 0.59% Ni and 0.06% Co (using a 0.6% Ni equivalent
More informationEffects of enhanced pyrite on the Galvanox process
Effects of enhanced pyrite on the Galvanox process Ghazaleh Nazari Supervisors: Dr. Dixon and Dr. Dreisinger The University of British Columbia Outline Chalcopyrite Leaching The Galvanox Process Motivations
More informationDeveloping Xanamem for Alzheimer s Dementia
Developing Xanamem for Alzheimer s Dementia Dr. Bill Ketelbey CEO, Actinogen Medical Investor Presentation March 2015 Forward Statements This presentation has been prepared by Actinogen Limited. ( Actinogen
More informationCorporate Presentation January 2019
TSXV & BVL:TK OTCPK: TKRFF www.tinkaresources.com Corporate Presentation January 2019 Disclaimer This presentation is not directed to, or intended for distribution to or use by, any person or entity that
More informationMacmillan Pass Zinc Project: Growing an Already World-Class Asset
Macmillan Pass Zinc Project: Growing an Already World-Class Asset January 2018 Cautionary Statements The following statements are required by Canadian securities legislation: Forward-Looking Statements:
More informationTamsulosin Hydrochloride 0.4 mg Capsule
Tamsulosin Hydrochloride 0.4 mg Capsule, Tamsulosin Hydrochloride 0.4 mg Capsule India, Tamsulosin Hydrochloride 0.4 mg Capsule manufacturers India, side effects Tamsulosin Hydrochloride 0.4 mg Capsule
More informationInvestment in MGC Pharmaceuticals
Investment in MGC Pharmaceuticals Investor Presentation May 2015 Disclaimer This presentation has been prepared by Erin Resources Limited ( Company ). It does not purport to contain all the information
More informationAFFIN HOLDINGS BERHAD (Company No.: W) (Incorporated in Malaysia under the Companies Act, 2016) NOTICE TO SHAREHOLDERS IN RELATION TO THE
THIS NOTICE IS FOR YOUR INFORMATION ONLY. YOU ARE NOT REQUIRED TO TAKE ANY ACTION. Bursa Malaysia Securities Berhad ( Bursa Securities ) takes no responsibility for the contents of this Notice, makes no
More informationDMX-200 for Diabetic Kidney Disease
DMX-200 for Diabetic Kidney Disease A/Prof David Packham MBBS(Hons), FRCP, FRACP, ARCP, MD Chief Medical Officer, Dimerix Nephrologist Bioshares Summit Queenstown, New Zealand 27 July 2018 Disclaimer Some
More informationItamar Medical. December Investors Presentation.
Itamar Medical December 2017. Investors Presentation. Disclaimer Itamar Medical Ltd. (the "Company") is furnishing this presentation and any information given during this presentation, solely for the consideration
More informationAssessment Report on Geochemical Work On The Following Claims
Assessment Report on Geochemical Work On The Following Claims Solid Gold 521566 Merrit High Grade Gold...545405 Iota 2 548002 Iota 548003 Merrit High Grade Ext 549081 PezimGold 562134 Iota 3 565569 Iota
More informationPROACTIVE INVESTOR PRESENTATION
www.thcl.com.au ASX RELEASE (16 th May 2017) PROACTIVE INVESTOR PRESENTATION The Hydroponics Company Limited (ASX: THC) is pleased to advise that Dr Andrew Beehag, Chief Executive Officer of Canndeo Limited,
More informationGF China Commodities Weekly
GF China Commodities Weekly CHINA ZINC CONCENTRATE SUPPLY WILL BE MORE DEPENDENT ON DOMESTIC MARKETIN 2H16 GFF Commodities Research Contacts : Bonnie Liu;852-3719 1155;bonnieliu@gfgroup.com.hk Zhang Ruoyi;020-85594189;zhangruoyi@gf.com.cn
More informationHARRISBURG UNIVERSITY PROJECT LEADERSHIP FORUM- CASE STUDY. Supporting the Marcellus Shale Boom
HARRISBURG UNIVERSITY PROJECT LEADERSHIP FORUM- CASE STUDY Supporting the Marcellus Shale Boom Marc Reeves, P.G. May 6, 2011 Outline Intro to SAIC Basics on the Marcellus Shale Natural gas demand Nationwide
More informationNOXOPHARM POSTS CORPORATE PRESENTATION AHEAD OF CONFERENCE ASX: NOX. Presentation at Singapore Investor Conference Review of first year of operation
Date 8 August 2017 Sydney, Australia ASX: NOX Noxopharm Limited ABN 50 608 966 123 Registered Office: Suite 1 Level 6 50 Queen St Melbourne VIC 3000 Australia Operations Office: Suite 3 Level 4 828 Pacific
More informationAkie & Kechika Regional Projects. Akie Project: Zn Pb Ag Cardiac Creek Deposit Advanced Exploration
Akie & Kechika Regional Projects Akie Project: Zn Pb Ag Cardiac Creek Deposit Advanced Exploration May 2018 1 Legal Disclaimer This presentation contains forward looking statements; including in particular,
More informationAppendix A Population Projection Study
Westhope Comprehensive Plan Appendix A Population Projection Study 48 K 3 W Keith Witwer & Associates Helping your community plan for the future February 27, 2012 Westhope, North Dakota Population Study
More informationMYOS RENS Technology CEO Joseph Mannello Issues Letter to Shareholders
December 14, 2018 MYOS RENS Technology CEO Joseph Mannello Issues Letter to Shareholders CEDAR KNOLLS, N.J., Dec. 14, 2018 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS),
More informationTransforming IVF and Biological Separations Presentation by Executive Chairman, Alison Coutts
Transforming IVF and Biological Separations Presentation by Executive Chairman, Alison Coutts NuSep (ASX:NSP) key facts No. shares 237,606,002 Market Cap. $7.1 million (@3 cps) No. of shareholders Approx.
More informationGlobal Insulin Pump Market with Focus on United States: Industry Analysis & Outlook ( )
Industry Research by Koncept Analytics Global Insulin Pump Market with Focus on United States: Industry Analysis & Outlook ----------------------------------------- (2018-2022) January 2019 1 Executive
More informationPutting ALK on the right growth trajectory
Putting ALK on the right growth trajectory Økonomisk Ugebrevs Kapitalmarkedseftermiddag 15. marts 2018 Per Plotnikof, VP Corporate Communications and IR Marts 2018 Allergy: a global disease with a large
More informationDARA Reports Year-End 2012 Financial Results
April 1, 2013 DARA Reports Year-End 2012 Financial Results Company Provides a Commercial Portfolio and Development Pipeline Business Update RALEIGH, NC -- (MARKETWIRE) -- 04/01/13 -- DARA BioSciences,
More informationFor personal use only
Australian Securities Exchange Limited Companies Announcements Office SYDNEY 4 April, 2012 New Australian Drug Developer Lists on ASX Key points Growth-focused Australian drug and therapeutic development
More informationNot an Offer for Securities
Not an Offer for Securities This presentation has been prepared by REVA Medical, Inc. (REVA or the Company) solely for its use at presentations to be made by the Company. This presentation does not constitute
More informationPressure acid leaching of zinc sulfide concentrate
Pressure acid leaching of zinc sulfide concentrate GU Yan( ), ZHANG Ting-an( ), LIU Yan( ), MU Wang-zhong( ), ZHANG Wei-guang( ) DOU Zhi-he( ), JIANG Xiao-li( ) Key Laboratory of Ecological Utilization
More informationFor personal use only
October 29 th, 2018 RotoGro to Acquire 100% of Canadian Lawful Cannabis License RotoGro to acquire 100% of the issued share capital of Supra THC from Valens GroWorks Corp. ( CSE:VGW ) Supra THC holds a
More informationUniversal Biosensors, Inc.
Universal Biosensors, Inc. ARBN 121 559 993 Buchan Three Tickers Presentation 18 th September 2013 1 Important Disclaimer This presentation is intended to provide a general outline only and is not intended
More informationMental Toronto Hydro
Mental Health @ Shirley Powell, Director, HR Planning, Systems & Rewards Benefits Canada s 2015 Healthy Outcomes Conference June 9-11, 2015 Niagara-on-the-Lake Company Overview Established in 1911 Largest
More informationSMARTPAY HOLDINGS LIMITED ANNUAL MEETING WEDNESDAY 26 SEPTEMBER 2017
SMARTPAY HOLDINGS LIMITED ANNUAL MEETING WEDNESDAY 26 SEPTEMBER 2017 Chair s Introduction Welcome Good morning and welcome to Smartpay s Annual Meeting for 2017. I m pleased to be speaking on behalf of
More informationWntResearch. Pearls on a string. 3 September 2018 PRICE EXPECTATIONS INVESTMENT CASE PRICE TRIGGERS PRICE 12 MONTHS COMPANY PROFILE
Occasion: Company announcements +32% +58% Pearls on a string has had troublesome times, but now everything seems to fall into place. With a new CEO in charge the phase II trials close to commencing in
More informationCompany overview. Highlights for the 1 st quarter 2018 (January-March)
Company overview Vaccibody is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies. The company is a leader in the rapidly developing field of
More informationPrima Biomed Ltd ASX CODE: PRR. Buy. Australian Biotech with Phase II/III Cancer Vaccine - Investment Summary. Action and Recommendation
29 January 2013 ASX CODE: PRR Buy Prima Biomed Ltd Australian Biotech with Phase II/III Cancer Vaccine - Investment Summary Capital Structure Sector Healthcare Share Price (A$) A$0.105 Target Price A$0.27
More informationXanADu: A Phase II trial of Xanamem TM in mild Alzheimer's disease
XanADu: A Phase II trial of Xanamem TM in mild Alzheimer's disease Dr Bill Ketelbey CEO 17TH ALZHEIMER'S AUSTRALIA BIENNIAL NATIONAL DEMENTIA CONFERENCE 19 OCTOBER 2017 Disclaimer This presentation has
More informationInvestor Presentation Post-Interim Results Update. September 2011
Investor Presentation Post-Interim Results Update September 2011 Disclaimer This presentation contains general information about the company s activities current as at 2 September 2011. It is provided
More informationA Zinc Play With A Bright Future. Corporate Presentation CSE: PSE FSE: PNX
A Zinc Play With A Bright Future Corporate Presentation CSE: PSE FSE: PNX Disclaimer The information contained in this presentation is provided by Pasinex Resources Limited. ( Pasinex ) for informational
More informationBIOTRON TO PRESENT AT AUSTRALIA BIOTECH INVEST 2013
Level 2, 66 Hunter Street Sydney NSW 2000 Tel: (61-2) 9300 3344 Fax: (61-2) 9221 6333 E-mail: pnightingale@biotron.com.au Website: www.biotron.com.au 28 October 2013 The Manager Companies ASX Limited 20
More informationGlobal Spine Market with Focus on Spinal Fusion: Industry Analysis & Outlook ( )
Industry Research by Koncept Analytics Global Spine Market with Focus on Spinal Fusion: Industry Analysis & Outlook ----------------------------------------- (2016-2020) December 2016 1 Executive Summary
More informationPORTFOLIO UNIT COST (C$) BOOK VALUE (C$) PRICE UNITS MARKET VALUE (C$) MFABC SHORT TRM BOND ,265, ,926, ,265,266.
ACCOUNT STATEMENT CITY OF WEST VANCOUVER September 30, 2015 Account #: 200000196-20 Cross-reference #: 875-1 Account Type: Non-Registered ACCOUNT SUMMARY AS OF SEPTEMBER 30, 2015 PORTFOLIO UNIT COST (C$)
More informationFor personal use only
Total Face Group Level 4, Bank House 11 19 Bank Place Melbourne 3000 www.totalfacegroup.com.au TOTAL FACE GROUP LTD 17th March 2016 Australian Securities Exchange Company Announcement Office Stock Exchange
More informationNewron announces 2018 financial results and provides outlook for 2019
Newron announces 2018 financial results and provides outlook for 2019 Milan, Italy, March 5, 2019 Newron Pharmaceuticals S.p.A. ( Newron ), a biopharmaceutical company focused on the development of novel
More informationAdvancing Pancreatic & Liver Cancer Treatment
ASX.OSL Advancing Pancreatic & Liver Cancer Treatment Australian Biotech Invest 2017 October 24 th Melbourne 1 Important notice This Presentation has been prepared by Ltd (ASX:OSL) (OncoSil or the Company)
More informationPLEO-CMT Top-line Results. Presentation October 16, 2018
PLEO-CMT Top-line Results Presentation October 16, 2018 Disclaimer References herein to this presentation (the Presentation ) shall mean and include this document, any oral presentation accompanying this
More informationThird-quarter results 2013
Third-quarter results 213 Fornebu, 6 November 213 Øyvind Eriksen and Leif Borge Agenda 213 Introduction Øyvind Eriksen Executive chairman Financials Leif Borge President & CFO Q&A Q&A session Øyvind Eriksen
More informationAerpio Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update
Aerpio Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update TIME-2b Clinical Trial of AKB-9778 in Patients with Diabetic Retinopathy Remains on Track Conference Call
More information2018: Growing & De-risking the Ayawilca Zinc Project in Peru
TSXV & BVL:TK OTCPK: TKRFF www.tinkaresources.com 2018: Growing & De-risking the Ayawilca Zinc Project in Peru Corporate Presentation May 2018 Disclaimer This presentation is not directed to, or intended
More informationNewLink Genetics Corporation Provides Operational Update and Reports Second Quarter 2015 Financial Results
July 31, 2015 NewLink Genetics Corporation Provides Operational Update and Reports Second Quarter 2015 Financial Results -Management to Host Conference Call Today at 8:30 a.m. ET- AMES, Iowa, July 31,
More informationA leading, global cannabis business. Investor Presentation
ASX:THC A leading, global cannabis business Investor Presentation March 2017 DISCLAIMER The material in this presentation (material) is not and does not constitute an offer, invitation or recommendation
More informationA Novel Dual-Opioid for Moderate to Severe Pain Management. May 2010
MoxDuo A Novel Dual-Opioid for Moderate to Severe Pain Management May 2010 Disclaimer This presentation, including information contained in this disclaimer, is given to you in strict confidence. By attending
More informationRULES OF CONDUCT OF INSIDERS RESPECTING
T RULES OF CONDUCT OF INSIDERS RESPECTING RADING O F SECURITIES OF TFI International lnc. Amended and restated July 2015 Executive Summary As an insider of TFI International Inc. ( TFI International )
More informationSprott Investment Conference July 17-20, Booth 6
Sprott Investment Conference July 17-20, 2018 Booth 6 Forward Looking Statements This presentation contains forward-looking information that involves substantial known and unknown risks and uncertainties,
More informationNitrazepam. Nitrazepam Tablets TAJ GROUP PHARMACEUTICAL B U S I N E S S. Generics. Active Ingredients: Each tablet contains 10 mg Nitrazepam
Nitrazepam, Nitrazepam India, Nitrazepam manufacturers India, side effects Nitrazepam manufacturers, Taj Pharma India, Nitrazepam overdose, Nitrazepam drug, Nitrazepam composition, Manufacturing Pharmaceutical,
More informationZacks Small-Cap Research
Zacks Small-Cap Research Sponsored Impartial - Comprehensive August 29, 2018 David Bautz, PhD 312-265-9471 dbautz@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Opiant Pharmaceuticals,
More informationGert Heylen Head of Genk Plant
Site visit 07 Genk plant June 7 th, 07 Bernard Hallemans Chief Operating Officer Europe Gert Heylen Head of Genk Plant Disclaimer Forward-Looking Statements This document may contain forward-looking information
More information